Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $2439.5 billion.

  • Universe Pharmaceuticals' Other Non-Current Liabilities changed 0.0% to $2439.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2439.5 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $2439.5 billion for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Other Non-Current Liabilities of $2439.5 billion as of Q3 2025, which was down 0.0% from $2439.5 billion recorded in Q3 2024.
  • Universe Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $2439.5 billion for Q3 2024, and its period low was $2.4 million during Q3 2021.
  • Over the past 5 years, Universe Pharmaceuticals' median Other Non-Current Liabilities value was $2.4 million (recorded in 2021), while the average stood at $609.9 billion.
  • In the last 5 years, Universe Pharmaceuticals' Other Non-Current Liabilities tumbled by 9999.99% in 2021 and then skyrocketed by 9999990000.0% in 2024.
  • Universe Pharmaceuticals' Other Non-Current Liabilities (Quarter) stood at $2.4 million in 2021, then changed by 0.0% to $2.4 million in 2022, then changed by 0.0% to $2.4 million in 2023, then surged by 99999900.0% to $2439.5 billion in 2024, then changed by 0.0% to $2439.5 billion in 2025.
  • Its Other Non-Current Liabilities stands at $2439.5 billion for Q3 2025, versus $2439.5 billion for Q3 2024 and $2.4 million for Q1 2024.